Frontlight ResearchEarly access
Trial site
Centro de Investigacion Clinica Chapultepec S.A. de C.V.
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Asthma1 trial
- Chronic kidney disease1 trial
- Crohn's disease1 trial
- IgA nephropathy1 trial
- Lung cancer1 trial
- Lupus (SLE)1 trial
- Multiple sclerosis1 trial
- Stroke1 trial
- Phase
- Phase 37 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Active, not recruiting5 trials
- Recruiting2 trials
- Completed1 trial
- Withdrawn1 trial
- Lead sponsor
- Hoffmann-La Roche2 trials
- Boehringer Ingelheim1 trial
- Janssen Research & Development, LLC1 trial
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 trial
- Nuvalent Inc.1 trial
- and 3 more
Running trials
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Active, not recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease1 recruiting
- Lung cancer1 recruiting
Closed trials
Withdrawn
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026